Paroxysmal Supraventricular Tachycardia

• CLINICAL_TRIALS trial_result · 2025-07-03
  Clinical Trial Update: APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias [NA]

  Completed results of the APART trial evaluating prevention and automatic therapy of atrial arrhythmias in patients with paroxysmal supravent…

• CLINICAL_TRIALS trial_result · 2025-05-28
  Clinical Trial Update: A Multicenter Study of Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia [NA]

  Clinical trial completion update for a multicenter study evaluating pulsed field ablation to treat paroxysmal supraventricular tachycardia (…

• CLINICAL_TRIALS trial_result · 2025-04-13
  Clinical Trial Update: prehospItal maNagement oF paroxysmaL supraventrICular Tachycardia

  The completed study assessed prehospital management of paroxysmal supraventricular tachycardia conducted in Bologna, Italy.

• CLINICAL_TRIALS trial_result · 2024-12-24
  Clinical Trial Update: Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia [Phase 3]

  Phase 3 trial evaluating etripamil nasal spray for self-administered termination of spontaneous episodes of paroxysmal supraventricular tach…

• CLINICAL_TRIALS trial_result · 2024-07-12
  Clinical Trial Update: Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT). [Phase 3]

  Milestone Pharmaceuticals announced termination of a Phase 3 trial evaluating etripamil for termination of spontaneous paroxysmal supraventr…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2024-05-23
  Clinical Trial Update: Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303 [Phase 3]

  Phase 3 safety study of etripamil nasal spray for paroxysmal supraventricular tachycardia has completed, with results posted.

• CLINICAL_TRIALS trial_result · 2023-04-24
  Clinical Trial Update: Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302 [Phase 3]

  Milestone's Phase 3 safety trial of intranasal ettripamil for terminating paroxysmal supraventricular tachycardia was terminated, with resul…

• CLINICAL_TRIALS trial_result · 2020-12-30
  Clinical Trial Update: Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm [Phase 2]

  Phase 2 trial evaluating intranasal MSP-2017 (etripamil) for converting paroxysmal supraventricular tachycardia to sinus rhythm; study compl…

• CLINICAL_TRIALS trial_result · 2012-11-14
  Clinical Trial Update: Oral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence Control [Phase 4]

  Phase 4 trial assessing oral verapamil for preventing recurrence of paroxysmal supraventricular tachycardia has been completed.

• CLINICAL_TRIALS trial_result · 2012-02-09
  Clinical Trial Update: Routine Mini-invasive Electrophysiology Study for Patients Feeling Tachycardia, With a Negative Holter ECG [NA]

  Completed clinical trial evaluating a routine mini-invasive electrophysiology study for patients with tachycardia and a negative Holter ECG.